LungCAD_NN :_: a_DT clinically_RB approved_VBN ,_, machine_NN learning_NN system_NN for_IN lung_NN cancer_NN detection_NN
We_PRP present_VBP LungCAD_NN ,_, a_DT computer_NN aided_VBN diagnosis_NN -LRB-_-LRB- CAD_NN -RRB-_-RRB- system_NN that_WDT employs_VBZ a_DT classification_NN algorithm_NN for_IN detecting_VBG solid_JJ pulmonary_JJ nodules_NNS from_IN CT_NN thorax_NN studies_NNS ._.
We_PRP briefly_RB describe_VBP some_DT of_IN the_DT machine_NN learning_NN techniques_NNS developed_VBD to_TO overcome_VB the_DT real_JJ world_NN challenges_NNS in_IN this_DT medical_JJ domain_NN ._.
The_DT most_RBS significant_JJ hurdle_NN in_IN transitioning_VBG from_IN a_DT machine_NN learning_NN research_NN prototype_NN that_WDT performs_VBZ well_RB on_IN an_DT in-house_JJ dataset_NN into_IN a_DT clinically_RB deployable_JJ system_NN ,_, is_VBZ the_DT requirement_NN that_IN the_DT CAD_NN system_NN be_VB tested_VBN in_IN a_DT clinical_JJ trial_NN ._.
We_PRP describe_VBP the_DT clinical_JJ trial_NN in_IN which_WDT LungCAD_NN was_VBD tested_VBN :_: a_DT large_JJ scale_NN multi-reader_JJ ,_, multi-case_JJ -LRB-_-LRB- MRMC_NN -RRB-_-RRB- retrospective_JJ observational_JJ study_NN to_TO evaluate_VB the_DT effect_NN of_IN CAD_NN in_IN clinical_JJ practice_NN for_IN detecting_VBG solid_JJ pulmonary_JJ nodules_NNS from_IN CT_NN thorax_NN studies_NNS ._.
The_DT clinical_JJ trial_NN demonstrates_VBZ that_IN every_DT radiologist_NN that_WDT participated_VBD in_IN the_DT trial_NN had_VBD a_DT significantly_RB greater_JJR accuracy_NN with_IN LungCAD_NN ,_, both_DT for_IN detecting_VBG nodules_NNS and_CC identifying_VBG potentially_RB actionable_JJ nodules_NNS ;_: this_DT ,_, along_IN with_IN other_JJ findings_NNS from_IN the_DT trial_NN ,_, has_VBZ resulted_VBN in_IN FDA_NNP approval_NN for_IN LungCAD_NN in_IN late_JJ 2006_CD ._.
